Bioventus Inc (BVS) Q3 2026 Earnings Call Highlights: Solid Pain and Ultrasonics Growth Offset ...
Bioventus Inc (BVS) delivered 3% revenue growth and 13% adjusted EPS growth while trimming full-year guidance on BGS headwinds and accelerating PNS investments. Related Stocks: BVS ,